Lingzi Luo
Lingzi Luo is an intervention scientist and a doctoral student at New York University School of Global Public Health. Her research interests are broadly in leveraging intervention optimization and implementation science methods to improve routine social and health services for vulnerable populations, especially those with chronic illnesses or mental health challenges. The ultimate goal of her research is to build learning service systems that are person-centered, efficient, and equitable. She had practice exposure in diverse settings such as community mental health centers, psychiatric inpatient units, non-profit organizations, local governments, and the World Health Organization headquarters. Prior to joining NYU, she worked for several years at Washington University School of Medicine on a national implementation science consortium to improve care for patients with sickle cell disease. Lingzi holds a B.S. in Psychology from Wuhan University and a dual-degree Master's in Social Work and Master's in Public Health with an individualized concentration in Integrated Health for Disadvantaged Populations from Washington University in St. Louis. She was a summer visiting student at the CGHE in 2023.
Yang, L., Luo, L., Choi, J., Ling, R., & Kleinman, A. (In Press). Principles: Stigma. Book chapter in the International Encyclopedia of Public Health, 3rd edition. Academic Press, Elsevier
Luo, L., Li, G., Tang, W., Wu, D., & Hall, B. (Submitted, Journal of Medical Internet Research). Intention to seek mental health services during the 2022 Shanghai COVID-19 city-wide lockdown.
Hoyt, C. R., Varughese, T. E., Erickson, J., Haffner, N., Luo, L., L’Hotta, A. J., et al. (2022). Developmental delay in infants and toddlers with sickle cell disease: A systematic review. Developmental Medicine & Child Neurology, 64(2), 168–175. https://doi.org/10.1111/dmcn.
Luo, L., King, A. A., Carroll, Y., Baumann, A. A., Brambilla, D., Carpenter, C. R., et al. (2021). Electronic health record–embedded individualized pain plans for emergency department treatment of vaso-occlusive episodes in adults with sickle cell disease: Protocol for a preimplementation and postimplementation study. JMIR Research Protocols, 10(4), e24818. https://doi.org/10.2196/24818